Publicaciones
...menos
1. Luzardo-Ocampo I, Ocampo-Ruiz AL, Dena-Beltrán JL, Martínez de la Escalera G, Clapp C, Macotela Y*. *Autor de correspondencia., The Diversity of Gut Microbiota at Weaning Is Altered in Prolactin Receptor-Null Mice., Nutrients, noviembre de 2023; 15(15), 3447
2. Isidor MS, Dong W, Servin-Uribe RI, Villarroel J, Altıntaş A, Ayala-Sumuano JT, Varela-Echavarría A, Barrès R, Stephanopoulos G, Macotela Y, Emanuelli B., Insulin resistance rewires the metabolic gene program and glucose utilization in human white adipocytes., International Journal of Obesity, marzo de 2022; 46(3), 535-543
3. Rodriguez-López LA, Torre-Villalvazo I, Aleman-Escondrillas G, Flores-López A, Guevara-Cruz M, Sánchez-Tapia M, Torre-Anaya EA, Martínez-López V, Vasquez-Reyes S, Torres-Villalobos GM, Macotela Y, Torres N, Tovar AR., The capacity of differentiation of stromal vascular fraction cells into beige adipocytes is markedly reduced in subjects with overweight/obesity and insulin resistance: effect of genistein., International Journal of Obesity, noviembre de 2021; 45(11), 2471-2481
4. Ramirez-Hernandez G, Adan-Castro E, Diaz-Lezama N, Ruiz-Herrera X, Martinez de la Escalera G, Macotela Y*, Clapp C*.
*AUTORES DE CORRESPONDENCIA, Global Deletion of the Prolactin Receptor Aggravates Streptozotocin-Induced Diabetes in Mice., Frontieres in Endocrinology (Lausanne), marzo de 2021; 12(619696)
5. Macotela Y, Triebel J, Clapp C., Time for a New Perspective on Prolactin in Metabolism., Trends In Endocrinology And Metabolism, abril de 2020; 31(4), 276-286
6. Ponce AJ, Galván-Salas T, Lerma-Alvarado RM, Ruiz-Herrera X, Hernández-Cortés T, Valencia-Jiménez R, Cárdenas-Rodríguez LE, Martínez de la Escalera G, Clapp C, Macotela Y., Low prolactin levels are associated with visceral adipocyte hypertrophy and insulin resistance in humans., Endocrine, febrero de 2020; 67(2), 331-343
7. De los Ríos EA, Ruiz-Herrera X, Tinoco-Pantoja V, López-Barrera F, Martínez de la Escalera G, Clapp C, Macotela Y., Impaired prolactin actions mediate altered offspring metabolism induced by maternal high-fat feeding during lactation., The FASEB Journal, junio de 2018; 32(3457), 3470
8. Moreno-Carranza B, Bravo-Manríquez M, Baez A, Ledesma-Colunga MG, Ruiz-Herrera X, Reyes-Ortega P, de Los Ríos EA, Macotela Y, Martínez de la Escalera G, Clapp C., Prolactin regulates liver growth during postnatal development in mice., AMERICAN JOURNAL OF PHYSIOLOGY: Regulatory, Integrative and Comparative Physiology, junio de 2018; 314, R902
9. Ruiz-Herrera X, de Los Ríos EA, Díaz JM, Lerma-Alvarado RM, de la Escalera LM, López-Barrera F, Lemini M, Arnold E, de la Escalera GM, Clapp C, Macotela Y., Prolactin Promotes Adipose Tissue Fitness and Insulin Sensitivity in Obese Males., Endocrinology, enero de 2017; 158(1), 56-68
10. Lemini M, Ruiz-Herrera X, Ledesma-Colunga MG, Díaz-Lezama N, De Los Ríos EA, Lopez-Barrera F, Méndez I, Martinez de la Escalera G, Macotela Y (autor de correspondencia), Clapp C. , Prolactin anterior pituitary expression and circulating levels are reduced in obese and diabetic rats: Role of TGFβ and TNFα., AMERICAN JOURNAL OF PHYSIOLOGY: Regulatory, Integrative and Comparative Physiology, febrero de 2015; 308(9), 792-799
11. S. Ussar, K. Y. Lee, S. N. Dankel, J. Boucher, M-F. Haering, A. Kleinridders, T. Thomou, R. Xue, Y. Macotela, A. M. Cypess, Y-H. Tseng, G. Mellgren, C. R. Kahn, ASC-1, PAT2, and P2RX5 are cell surface markers for white, beige, and brown adipocytes. Sci. Transl. Med. 6, 247ra103 (2014)., ASC-1, PAT2, and P2RX5 are cell surface markers for white, beige, and brown adipocytes., Science Translational Medicine, julio de 2014; 6(247), 247ra103
12. Macotela Y, El tejido adiposo: protagonista central de la obesidad, Gaceta UNAM-Juriquilla, marzo de 2013; (23), 8-9
13. Becerril-Campos AA, Ramos-Gómez M, De Los Ríos-Arellano EA, Ocampo-Anguiano PV, González-Gallardo A, Macotela Y, García-Gasca T, Ahumada-Solórzano SM., Bean Leaves Ameliorate Lipotoxicity in Fatty Liver Disease., Nutrients, noviembre de 2023; 15(13), 2928
14. Ruiz-Herrera X*, Luzardo-Ocampo I, Martínez de la Escalera G, Clapp C, Macotela Y*. *Autor de correspondencia., Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance., JOVE, noviembre de 2023; 192
15. Luzardo-Ocampo I, Dena-Beltrán JL, Ruiz-Herrera X, Ocampo-Ruiz AL, Martínez de la Escalera G, Clapp C, Macotela Y*. *Autor de correspondencia., Obesity-derived alterations in the lactating mammary gland: Focus on prolactin., Molecular and Cellular Endocrinology, enero de 2023; 559
16. Macotela Y*, Ruiz-Herrera X, Vázquez-Carrillo DI, Ramírez-Hernandez G, Martínez de la Escalera G, Clapp C. *Autor de correspondencia., The beneficial metabolic actions of prolactin., Frontieres in Endocrinology (Lausanne), septiembre de 2022; 13
17. Martínez de la Escalera G, Macotela Y, Clapp C., A New Experimental Tool Toward Understanding the Regulation of Human Prolactin Secretion and Functions. , Endocrinology, abril de 2022; 163(4)
18. Vázquez-Membrillo M, Siqueiros-Márquez L, Núñez FF, Díaz-Lezama N, Adán-Castro E, Ramírez-Hernández G, Adán N, Macotela Y, Martínez de la Escalera G, Clapp C., Prolactin stimulates the vascularisation of the retina in newborn mice under hyperoxia conditions, Journal Of Neuroendocrinology, mayo de 2020; 32(11), e12858
19. Triebel J, Moreno-Vega AI, Vázquez-Membrillo M, Nava G, García-Franco R, López-Star E, Baldivieso-Hurtado O, Ochoa D, Macotela Y, Bertsch T, Martinez de la Escalera G, Clapp C. , High Prolactin Excretion in Patients with Diabetes Mellitus and Impaired Renal Function, Clinical Laboratory, julio de 2015; 61(7), 709-716
20. Clapp, C., Thebault, S., Macotela, Y., Moreno-Carranza, B., Triebel, J., Martínez de la Escalera, G., Regulation of blood vessels by prolactin and vasoinhibins., Advances In Experimental Medicine And Biology, enero de 2015; 846, 83-95
21. Londraville RL, Macotela Y, Duff RJ, Easterling MR, Liu Q, Crespi EJ., Comparative endocrinology of leptin: Assessing function in a phylogenetic context., General And Comparative Endocrinology, febrero de 2014
22. Vernochet C, Mourier A, Bezy O, Macotela Y, Boucher J, Rardin MJ, An D, Lee KY, Ilkayeva OR, Zingaretti CM, Emanuelli B, Smyth G, Cinti S, Newgard CB, Gibson BW, Larsson NG, Kahn CR, Adipose-specific deletion of TFAM increases mitochondrial oxidation and protects mice against obesity and insulin resistance., Cell metabolism, diciembre de 2012; 16(6), 765-76
23. Mori MA, Raghavan P, Thomou T, Boucher J, Robida-Stubbs S, Macotela Y, Russell SJ, Kirkland JL, Blackwell TJ, Kahn CR. , Role of MicroRNA Processing in Adipose Tissue in Stress Defense and Longevity., Cell metabolism, octubre de 2012; 16(3), 336-347
24. Macotela Y, Emanuelli B, Mori M, Schulz T, Gesta S, Tseng Y, Kahn CR., Intrinsic Differences in Adipocyte Precursor Cells from Different White Fat Depots. , Diabetes, julio de 2012; 61(7), 1691-1699
25. Boucher J, Mori MA, Lee KY, Smyth G, Liew CW, Macotela Y, Rourk M, Bluher M, Russell SJ, Kahn CR. , Impaired thermogenesis and adipose tissue development in mice with fat-specific disruption of insulin and IGF-1 signalling., Nature Communications, junio de 2012; 3, 902
26. Yazmin Macotela, Brice Emanuelli, Anneli M Bång, Daniel O Espinoza, Jeremie Boucher, Kirk Beebe, Walter Gall and C. Ronald Kahn, Dietary Leucine - an Environmental Modifier of Insulin Resistance Acting on Multiple Levels of Metabolism, Plos One, 2011; (6), e2187
27. Triebel J, Macotela Y, Martinez de la Escalera G, Clapp C., PROLACTIN AND VASOINHIBINS: ENDOGENOUS PLAYERS IN DIABETIC RETINOPATHY, International Union of Biochemistry and Molecular Biology - IUBMB Life, septiembre de 2011
28. Gesta S, Bezy O, Mori, M, Macotela, Y, Lee K Kahn CR., The Mesodermal Developmental Gene Tbx15 Impairs Adipocyte Differentiation and Mitochondria Respiration, Proceedings Of The National Academy Of Sciences Of The United States Of America, febrero de 2011; 108(7), 2771-2776
29. Boucher J, Macotela Y, Bezy O, Mori MA, Kriauciunas K, Kahn CR.
, A Kinase-Independent Role for Unoccupied Insulin and IGF-1 Receptors in the Control of Apoptosis.
, Science Signaling, diciembre de 2010; 3(151), ra87 1-10
30. Macotela Y, Boucher J, Tran TT, Kahn CR., Gender and Depot Differences in Adipocyte Insulin Sensitivity and Glucose Metabolism. , Diabetes, 2009; 58, 803-812
31. Emanuelli B, Macotela Y, Boucher J, Kahn CR., SOCS-1 deficiency does not prevent diet-induced insulin resistance., Biochemical And Biophysical Research Communication, 2008; 377, 447-452
32. García C, Aranda J, Arnold E, Thébault S, Macotela Y, López-Casillas F, Mendoza V, Quiroz-Mercado H, Hernández-Montiel HL, Lin SH, de la Escalera GM, Clapp C., Vasoinhibins prevent retinal vasopermeability associated with diabetic retinopathy in rats via protein phosphatase 2A-dependent eNOS inactivation., Journal Of Clinical Investigation, 2008; 118, 2291-2300
33. González C, Parra A, Ramírez-Peredo J, García C, Rivera JC, Macotela Y, Aranda J, Lemini M, Arias J, Ibargüengoitia F, de la Escalera GM, Clapp C., Elevated vasoinhibins may contribute to endothelial cell dysfunction and low birth weight in preeclampsia. , Laboratory Investigation, 2007; 87, 1009-1017
34. Clapp C, Gonzalez C, Macotela Y, Aranda J, Rivera JC, Garcia C, Guzman J, Zamorano M, Vega C, Martin C, Jeziorski MC, Martinez de la Escalera G., Vasoinhibins: A Family of N-Terminal Prolactin Fragments that Inhibit Angiogenesis and Vascular Function., Frontiers Of Hormone Research, 2006; 35, 64-73
35. Macotela Y, Aguilar M, Guzmán-Morales J, Rivera JC, Zermeño C, Lopez-Barrera F, Nava G, Lavalle C, Martinez de la Escalera G and Clapp C., Matrix metalloproteases from chondrocytes generate an antiangiogenic 16kDa prolactin. , Journal Of Cell Science, 2006; 119, 1790-1800
36. Zermeño C, Guzmán-Morales J, Macotela Y, Nava G, Lopez-Barrera F, Kouri JB, Lavalle C, Martinez de la Escalera G and Clapp C., Prolactin inhibits the apoptosis of chondrocytes induced by serum starvation., Journal Of Endocrinology, 2006; 189, R1-R8
37. Montes de Oca P, Macotela Y, Nava G, López-Barrera F, Martínez de la Escalera G, Clapp C., Prolactin stimulates integrin mediated adhesion of circulating mononuclear cells to endothelial cells., Laboratory Investigation, 2005; 85, 633-642
38. Dueñas Z, Rivera JC, Quiróz-Mercado H, Aranda J, Macotela Y, Montes de Oca P, López-Barrera F, Nava G, Guerrero JL, Suarez A, De Regil M, Martinez de la Escalera G, Clapp C., Prolactin in the eye of patients with retinopathy of prematurity: implications for vascular regression., Investigative Ophthalmology & Visual Science, 2004; 45, 2049-2055
39. Corbacho AM*, Macotela Y*, Nava G, Eiserich, JP, Cross CE, Martínez de la Escalera G, Clapp C., Cytokine induction of prolactin receptors mediates prolactin inhibition of nitric oxide synthesis in pulmonary fibroblasts., Febs Letters, 2003; 544, 171-175
40. Macotela Y, Mendoza C, Corbacho AM, Cosío G, Eiserich JP, Zentella A, Martínez de la Escalera G, Clapp C., 16K prolactin induces NF-kB activation in pulmonary fibroblasts., Journal Of Endocrinology, 2002; 175, R13-R18
41. Corbacho A, Macotela Y, Nava G, Torner L, Dueñas Z, Noris G, Morales MA, Martínez de la Escalera G, Clapp C., Human umbilical vein endothelial cells express multiple prolactin isoforms., Journal Of Endocrinology, 2000; 166, 53-62
42. Corbacho AM, Nava G, Eiserich JP, Noris G, Macotela Y, Struman I, Martinez de la Escalera G, Freeman B, Clapp C. , Proteolytic cleavage confers NO synthase inducing activity upon prolactin., Journal Of Biological Chemistry, 2000; 275, 13183-13186
43. Clapp C, López-Gómez FJ, Nava G, Corbacho A, Torner L, Macotela Y, Dueñas Z, Ochoa A, Noris G, Acosta E, Garay E, Martínez de la Escalera G., Expression of prolactin mRNA and of prolactin-like proteins in endothelial cells: evidence for autocrine effects., Journal Of Endocrinology, 1998; 158, 137-144
44. Dominguez V, Gevorkian G, Govezensky T, Rodriguez H, Viveros M, Cocho G, Macotela Y, Masso F, Pacheco M, Estrada JL, Lavalle C, Larralde C., Antigenic Homology of HIV-1 GP41 and human platelet glycoprotein GPIIIa (integrin 3). , Journal of Acquired Immune Deficiency Syndromes, 1998; 17, 385-390